ammonium hydroxide and losartan

ammonium hydroxide has been researched along with losartan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagami, GT2
Ali, SS; Gazzaz, ZJ; Ibraheem, MS; Murad, HA1

Other Studies

3 other study(ies) available for ammonium hydroxide and losartan

ArticleYear
Enhanced ammonia secretion by proximal tubules from mice receiving NH(4)Cl: role of angiotensin II.
    American journal of physiology. Renal physiology, 2002, Volume: 282, Issue:3

    Topics: Acid-Base Equilibrium; Acids; Amiloride; Ammonia; Ammonium Chloride; Angiotensin II; Animals; Antihypertensive Agents; Carbon Dioxide; Diuretics; Kidney Tubules, Proximal; Losartan; Male; Mice; Microcirculation; Potassium; Renal Circulation; Vasoconstrictor Agents

2002
Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis.
    American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:4

    Topics: Acidosis; Ammonia; Ammonium Chloride; Angiotensin II; Animals; Disease Models, Animal; Kidney Cortex; Kidney Tubules, Proximal; Losartan; Male; Mice; Perfusion

2008
Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2017, Sep-21, Volume: 50, Issue:11

    Topics: Alanine Transaminase; Ammonia; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; End Stage Liver Disease; Enzyme-Linked Immunosorbent Assay; gamma-Glutamyltransferase; Glutathione; Liver; Liver Cirrhosis; Locomotion; Losartan; Male; Malondialdehyde; Motor Disorders; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Thioacetamide; Treatment Outcome; Tumor Necrosis Factor-alpha

2017